Clinical Trial Update: BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) [Phase 4]

View source ↗

Summary

The BOOST Phase 4 trial evaluating increased dosage of lopinavir/ritonavir for HIV infections was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Community Research Initiative of New England | Conditions: HIV Infections | Phase 4 | Status: TERMINATED